These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32424916)

  • 1. Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply.
    Malham M; Jakobsen C; Paerregaard A; Hald M; Virta L; Kolho KL; Wewer V
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1214-1215. PubMed ID: 32424916
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: suicide and IBD-a call to action. Authors' reply.
    Malham M; Jakobsen C; Hald M; Paerregaard A; Virta LJ; Kolho KL; Wewer V
    Aliment Pharmacol Ther; 2019 Jul; 50(1):106-107. PubMed ID: 31184387
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: suicide risk among adult inflammatory bowel disease patients.
    Sánta A; Szántó KJ; Sarlós P; Miheller P; Farkas K; Molnár T
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1213-1214. PubMed ID: 32424920
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: suicide and IBD-a call to action.
    Banerjee T; Gearry R
    Aliment Pharmacol Ther; 2019 Jul; 50(1):105-106. PubMed ID: 31184390
    [No Abstract]   [Full Text] [Related]  

  • 5. The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study.
    Malham M; Jakobsen C; Paerregaard A; Virta LJ; Kolho KL; Wewer V
    Aliment Pharmacol Ther; 2019 Jul; 50(1):33-39. PubMed ID: 31069829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease - authors' reply.
    Diederen K; Hoekman DR; Benninga MA
    Aliment Pharmacol Ther; 2016 Aug; 44(3):309-10. PubMed ID: 27375102
    [No Abstract]   [Full Text] [Related]  

  • 7. Autopsy rate in suicide is low among elderly in Denmark compared with Finland.
    Ylijoki-Sørensen S; Boldsen JL; Boel LW; Bøggild H; Lalu K; Sajantila A
    Forensic Sci Int; 2014 Nov; 244():158-65. PubMed ID: 25244292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors' reply.
    Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert C
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1241-2. PubMed ID: 27137729
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: screening for adrenal suppression in paediatric inflammatory bowel disease - authors' reply.
    Philpott H; Dougherty MK; Dellon ES
    Aliment Pharmacol Ther; 2018 Oct; 48(8):885-886. PubMed ID: 30281837
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Mendelian randomization - new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply.
    Massironi S; Viganò C; Danese S
    Aliment Pharmacol Ther; 2023 Jul; 58(1):145-146. PubMed ID: 37307554
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: risk factors and impacts of psychological morbidity in young people with inflammatory bowel disease - authors' reply.
    Brooks AJ; Rowse G; Ryder A; Peach EJ; Corfe BM; Lobo AJ
    Aliment Pharmacol Ther; 2016 Aug; 44(4):426. PubMed ID: 27413001
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease - authors' reply.
    de Francisco R; Castaño-García A; Riestra S
    Aliment Pharmacol Ther; 2019 Feb; 49(4):477-478. PubMed ID: 30689254
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: thiopurine/anti-TNF use during pregnancy-more encouraging safety data. Authors' reply.
    Mertz Nørgård B; Friedman S
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1411. PubMed ID: 33105975
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: causes of fatigue in inflammatory bowel disease remain uncertain - authors' reply.
    Artom M; Czuber-Dochan W; Norton C
    Aliment Pharmacol Ther; 2017 Mar; 45(5):763-764. PubMed ID: 28150457
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: validated fatigue questionnaires in inflammatory bowel diseases--authors' reply.
    Czuber-Dochan W; Norton C
    Aliment Pharmacol Ther; 2014 Feb; 39(3):342. PubMed ID: 24397324
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: combination of biologics in inflammatory bowel diseases. Authors' reply.
    Yang E; Panaccione N; Whitmire N; Dulai PS; Vande Casteele N; Singh S; Boland BS; Collins A; Sandborn WJ; Panaccione R; Battat R
    Aliment Pharmacol Ther; 2020 Aug; 52(3):568-569. PubMed ID: 32656846
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: inflammatory bowel disease guidelines and conflicts of interest--authors' reply.
    Feuerstein JD; Leffler DA; Cheifetz AS
    Aliment Pharmacol Ther; 2013 Aug; 38(4):445-6. PubMed ID: 23855400
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter: diagnostic delay in inflammatory bowel disease-Authors' reply.
    Pollok RC; Baillie S; Jayasooriya N; Blackwell J; Petersen I; Bottle A; Saxena S;
    Aliment Pharmacol Ther; 2023 May; 57(10):1205-1206. PubMed ID: 37094317
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.
    Christensen B; Gibson PR; Rubin DT
    Aliment Pharmacol Ther; 2018 May; 47(10):1423-1424. PubMed ID: 29676007
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: dermatological complications with therapy for inflammatory bowel disease--authors' reply.
    Ghosh S; Moran GW
    Aliment Pharmacol Ther; 2014 Jan; 39(2):233-4. PubMed ID: 24330245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.